Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Video library· Longevity Geek Lab

Aging Cells and Chronic Inflammation — Part 8

Thumbnail from YouTube. Playing loads the YouTube player.

History & recommendationsOff

Keep recently viewed content on this browser. Your history stays on this device and is never sent to Harbor. Videos you play can also help order related video recommendations.

Up to 120 items · 90 days. Turning this off deletes the history.
Open saved items & history →

About this video

Creator description · original language

As we age, some cells enter a state called senescence. They stop dividing — but they do not die. Instead, they continue releasing inflammatory signals that contribute to a process called inflammaging. Senescence itself is not inherently harmful. It helps suppress damaged cells and supports tissue repair. The problem is accumulation over time, combined with reduced immune clearance during aging. This creates a self-reinforcing inflammatory cycle linked to aging biology itself. Research into senolytics, autophagy, and cellular aging is now one of the fastest-growing areas in longevity science — but much of the clinical evidence in humans is still emerging. This is Part 8 of the chronic inflammation series. Keywords inflammaging, senescent cells, SASP, chronic inflammation, aging biology, longevity science, senolytics, fisetin, quercetin, dasatinib, autophagy, cellular senescence, healthy aging, mitochondrial health, DNA repair, anti aging science, women over 40, chronic disease, evidence based longevity, chronic inflammation series

Longevity Geek Lab · 2 min · Source published: 2026-05-26

Added to Harbor: 10/22/2026

Original on YouTube ↗

Automatically categorized source. Creator statements are not an independent evidence review or personal medical guidance.

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…